An outbreak of hantavirus pulmonary syndrome, Chile, 1997

Fil: Toro, Jorge. Ministry of Health; Chile.Fil: Vega, Jeanette D. Pan American Health Organization; Chile.Fil: Khan, Ali S. Centers for Disease Control and Prevention; Estados Unidos.Fil: Mills, James N. Centers for Disease Control and Prevention; Estados Unidos.Fil: Padula, Paula. ANLIS Dr.C.G.Malbrán. Instituto Nacional de Enfermedades Infecciosas; Argentina.Fil: Terry, William. Centers for Disease Control and Prevention; Estados Unidos.Fil: Yadón, Zaida. ANLIS Dr.C.G.Malbrán. Instituto Nacional de Enfermedades Infecciosas; Argentina.Fil: Valderrama, Rosa. Aysen Region XI Health Service; Chile.Fil: Ellis, Barbara A. Centers for Disease Control and Prevention; Estados Unidos.Fil: Pavletic, Carlos. Ministry of Health; Chile.Fil: Cerda, Rodrigo. Pan American Health Organization; Chile.Fil: Zaki, Sherif. Centers for Disease Control and Prevention; Estados Unidos.Fil: Wun-Ju, Shieh. Centers for Disease Control and Prevention; Estados Unidos.Fil: Meyer, Richard. Centers for Disease Control and Prevention; Estados Unidos.Fil: Tapia, Mauricio. Coyhaique Regional Hospital; Chile.Fil: Mansilla, Carlos. Coyhaique Regional Hospital; Chile.Fil: Baro, Michel. Llanchipal Health Services; Chile.Fil: Vergara, Jose A. Llanchipal Health Services; Chile.Fil: Concha, Marisol. Ministry of Health; Chile.Fil: Calderón, Gladys. ANLIS Dr.C.G.Malbrán. Instituto Nacional de Enfermedades Virales Humanas Dr. Julio Maiztegui; Argentina.Fil: Enria, Delia. ANLIS Dr.C.G.Malbrán. Instituto Nacional de Enfermedades Virales Humanas Dr. Julio Maiztegui; Argentina.Fil: Peters, C.J. Centers for Disease Control and Prevention; Estados Unidos.Fil: Ksiazek, Thomas G. Centers for Disease Control and Prevention; Estados Unidos.An outbreak of 25 cases of Andes virus-associated hantavirus pulmonary syndrome (HPS) was recognized in southern Chile from July 1997 through January 1998. In addition to the HPS patients, three persons with mild hantaviral disease and one person with asymptomatic acute infection were identified. Epidemiologic studies suggested person-to-person transmission in two of three family clusters. Ecologic studies showed very high densities of several species of sigmodontine rodents in the area

An outbreak of hantavirus pulmonary syndrome, Chile, 1997

Fil: Toro, Jorge. Ministry of Health; Chile.Fil: Vega, Jeanette D. Pan American Health Organization; Chile.Fil: Khan, Ali S. Centers for Disease Control and Prevention; Estados Unidos.Fil: Mills, James N. Centers for Disease Control and Prevention; Estados Unidos.Fil: Padula, Paula. ANLIS Dr.C.G.Malbrán. Instituto Nacional de Enfermedades Infecciosas; Argentina.Fil: Terry, William. Centers for Disease Control and Prevention; Estados Unidos.Fil: Yadón, Zaida. ANLIS Dr.C.G.Malbrán. Instituto Nacional de Enfermedades Infecciosas; Argentina.Fil: Valderrama, Rosa. Aysen Region XI Health Service; Chile.Fil: Ellis, Barbara A. Centers for Disease Control and Prevention; Estados Unidos.Fil: Pavletic, Carlos. Ministry of Health; Chile.Fil: Cerda, Rodrigo. Pan American Health Organization; Chile.Fil: Zaki, Sherif. Centers for Disease Control and Prevention; Estados Unidos.Fil: Wun-Ju, Shieh. Centers for Disease Control and Prevention; Estados Unidos.Fil: Meyer, Richard. Centers for Disease Control and Prevention; Estados Unidos.Fil: Tapia, Mauricio. Coyhaique Regional Hospital; Chile.Fil: Mansilla, Carlos. Coyhaique Regional Hospital; Chile.Fil: Baro, Michel. Llanchipal Health Services; Chile.Fil: Vergara, Jose A. Llanchipal Health Services; Chile.Fil: Concha, Marisol. Ministry of Health; Chile.Fil: Calderón, Gladys. ANLIS Dr.C.G.Malbrán. Instituto Nacional de Enfermedades Virales Humanas Dr. Julio Maiztegui; Argentina.Fil: Enria, Delia. ANLIS Dr.C.G.Malbrán. Instituto Nacional de Enfermedades Virales Humanas Dr. Julio Maiztegui; Argentina.Fil: Peters, C.J. Centers for Disease Control and Prevention; Estados Unidos.Fil: Ksiazek, Thomas G. Centers for Disease Control and Prevention; Estados Unidos.An outbreak of 25 cases of Andes virus-associated hantavirus pulmonary syndrome (HPS) was recognized in southern Chile from July 1997 through January 1998. In addition to the HPS patients, three persons with mild hantaviral disease and one person with asymptomatic acute infection were identified. Epidemiologic studies suggested person-to-person transmission in two of three family clusters. Ecologic studies showed very high densities of several species of sigmodontine rodents in the area

Germline variation at 8q24 and prostate cancer risk in men of European ancestry

Chromosome 8q24 is a susceptibility locus for multiple cancers, including prostate cancer. Here we combine genetic data across the 8q24 susceptibility region from 71,535 prostate cancer cases and 52,935 controls of European ancestry to define the overall contribution of germline variation at 8q24 to prostate cancer risk. We identify 12 independent risk signals for prostate cancer (p < 4.28 × 10−15), including three risk variants that have yet to be reported. From a polygenic risk score (PRS) model, derived to assess the cumulative effect of risk variants at 8q24, men in the top 1% of the PRS have a 4-fold (95%CI = 3.62–4.40) greater risk compared to the population average. These 12 variants account for ~25% of what can be currently explained of the familial risk of prostate cancer by known genetic risk factors. These findings highlight the overwhelming contribution of germline variation at 8q24 on prostate cancer risk which has implications for population risk stratification

Germline variation at 8q24 and prostate cancer risk in men of European ancestry.

Chromosome 8q24 is a susceptibility locus for multiple cancers, including prostate cancer. Here we combine genetic data across the 8q24 susceptibility region from 71,535 prostate cancer cases and 52,935 controls of European ancestry to define the overall contribution of germline variation at 8q24 to prostate cancer risk. We identify 12 independent risk signals for prostate cancer (p < 4.28 × 10-15), including three risk variants that have yet to be reported. From a polygenic risk score (PRS) model, derived to assess the cumulative effect of risk variants at 8q24, men in the top 1% of the PRS have a 4-fold (95%CI = 3.62-4.40) greater risk compared to the population average. These 12 variants account for ~25% of what can be currently explained of the familial risk of prostate cancer by known genetic risk factors. These findings highlight the overwhelming contribution of germline variation at 8q24 on prostate cancer risk which has implications for population risk stratification